(E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane

C50H82N5O7P — CID 157139085

IUPAC(E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane
SMILESC.CC[C@H]1O[C@@H](n2cc(/C=C/C(=O)NCCCC(=O)CC[C@@H](C)[C@H]3CC[C@H]4[C@@H]5CC[C@@H]6CCCC[C@]6(C)[C@H]5CC[C@]34C)c(=O)[nH]c2=O)CC1OP(OCCC#N)N(C(C)C)C(C)C
InChIInChI=1S/C49H78N5O7P.CH4/c1-9-42-43(61-62(59-29-13-27-50)54(32(2)3)33(4)5)30-45(60-42)53-31-35(46(57)52-47(53)58)17-23-44(56)51-28-12-15-37(55)19-16-34(6)39-21-22-40-38-20-18-36-14-10-11-25-48(36,7)41(38)24-26-49(39,40)8;/h17,23,31-34,36,38-43,45H,9-16,18-22,24-26,28-30H2,1-8H3,(H,51,56)(H,52,57,58);1H4/b23-17+;/t34-,36+,38+,39-,40+,41+,42-,43?,45-,48+,49-,62?;/m1./s1
InChIKeyAJZAWBJWZHWAGQ-BOBNRFPYSA-N
MW896.21 g/mol
LogP10.48
Rot. Bonds20

About (E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane

(E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane (PubChem CID 157139085) has the molecular formula C50H82N5O7P and a molecular weight of 896.21 g/mol. Its IUPAC name is (E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane.

Molecular Properties

Compound Name(E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane
PubChem CID157139085
Molecular FormulaC50H82N5O7P
Molecular Weight896.21 g/mol
Exact Mass895.60
IUPAC Name(E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane
SMILESC.CC[C@H]1O[C@@H](n2cc(/C=C/C(=O)NCCCC(=O)CC[C@@H](C)[C@H]3CC[C@H]4[C@@H]5CC[C@@H]6CCCC[C@]6(C)[C@H]5CC[C@]34C)c(=O)[nH]c2=O)CC1OP(OCCC#N)N(C(C)C)C(C)C
InChIInChI=1S/C49H78N5O7P.CH4/c1-9-42-43(61-62(59-29-13-27-50)54(32(2)3)33(4)5)30-45(60-42)53-31-35(46(57)52-47(53)58)17-23-44(56)51-28-12-15-37(55)19-16-34(6)39-21-22-40-38-20-18-36-14-10-11-25-48(36,7)41(38)24-26-49(39,40)8;/h17,23,31-34,36,38-43,45H,9-16,18-22,24-26,28-30H2,1-8H3,(H,51,56)(H,52,57,58);1H4/b23-17+;/t34-,36+,38+,39-,40+,41+,42-,43?,45-,48+,49-,62?;/m1./s1
InChIKeyAJZAWBJWZHWAGQ-BOBNRFPYSA-N
XLogP10.48
TPSA155.75 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds20
Heavy Atoms63
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500896.21
LogP ≤ 510.48
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze (E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane?
The IUPAC name of (E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane (CID 157139085) is (E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane.
What is the SMILES notation for (E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane?
The canonical SMILES for (E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane is C.CC[C@H]1O[C@@H](n2cc(/C=C/C(=O)NCCCC(=O)CC[C@@H](C)[C@H]3CC[C@H]4[C@@H]5CC[C@@H]6CCCC[C@]6(C)[C@H]5CC[C@]34C)c(=O)[nH]c2=O)CC1OP(OCCC#N)N(C(C)C)C(C)C.
What is the InChIKey of (E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane?
The InChIKey is AJZAWBJWZHWAGQ-BOBNRFPYSA-N. The full InChI is InChI=1S/C49H78N5O7P.CH4/c1-9-42-43(61-62(59-29-13-27-50)54(32(2)3)33(4)5)30-45(60-42)53-31-35(46(57)52-47(53)58)17-23-44(56)51-28-12-15-37(55)19-16-34(6)39-21-22-40-38-20-18-36-14-10-11-25-48(36,7)41(38)24-26-49(39,40)8;/h17,23,31-34,36,38-43,45H,9-16,18-22,24-26,28-30H2,1-8H3,(H,51,56)(H,52,57,58);1H4/b23-17+;/t34-,36+,38+,39-,40+,41+,42-,43?,45-,48+,49-,62?;/m1./s1.
What are the key properties of (E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane?
(E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane has a molecular weight of 896.21 g/mol, XLogP of 10.48, 20 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-3-[1-[(2R,5R)-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-5-ethyloxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[(7R)-7-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-oxooctyl]prop-2-enamide;methane is sourced from PubChem (CID 157139085), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).